Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Ape Diseases
MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.
The correct dose: pharmacologically guided end point for anti-growth factor therapy.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The correct dose: pharmacologically guided end point for anti-growth factor therapy.
The correct dose: pharmacologically guided end point for anti-growth factor therapy. Cancer Res. 1992 May 01; 52(9 Suppl):2743s-2746s.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Carcinoma, Small Cell
Cell Division
Dose-Response Relationship, Drug
Gastrin-Releasing Peptide
Humans
Lung Neoplasms
Models, Biological
Peptides
authors with profiles
James L. Mulshine